Depression App Moodpath Turns One Year Old: Over 100.000 Users, more than 25.000 Electronic Referral Letters Created

MoodpathOctober 10, 2017 was the date of the World Mental Health Day. On the same day, Moodpath, the app for the early recognition of depression, has been on the market for one year. Moodpath has been downloaded by more than 100.000 users and more than 25.000 referral letters for further treatment by healthcare professionals have been created by the app. Moodpath is already the number one app for the term “depression” on the iOS App Stores in the UK, Canada, Australia, Germany, Austria, Switzerland, and the Netherlands. The user ratings are overwhelmingly positive (with an average rating of 4.7 out of 5).

The CE-certified medical app aims to improve the recognition of depression - with the help of an algorithm and the analysis of anonymous data. "To this day, 90 percent of the people affected don't get the treatment they need. According to the WHO more than 320 million people worldwide suffer from depression. And every month there are more than 30 million Google searches on this topic. There simply is no alternative to the complementary use of digital medical products like Moodpath, if we finally want to reduce the treatment gap in mental healthcare," says Felix Frauendorf, founder of Berlin-based Aurora Health, the company behind Moodpath.

The scientific validation of Moodpath is of particular importance to the founders. Three studies are currently being conducted, including one at the Free University of Berlin. Additional research projects in the United States are about to commence: "We are currently in contact with researchers and data scientists at Columbia University and Stanford. It is our goal to constantly use studies and the latest scientific findings to further develop our mobile depression screening," stresses Mark Goering, clinical psychologist and founder of Aurora Health. Moodpath will shortly expand its services to include customized daily plans. These plans are individually tailored to the needs of each user, adapt to progress made, and include psychological exercises based on cognitive behavioural therapy.

For further information, please visit:
http://www.moodpath.io

About Moodpath
Moodpath is a mobile mental health app for the detection and treatment of depression. The app includes a user-friendly screening and improvement program. Based on an algorithm the program adapts to each individual user. The app is linked to Aurora, a platform that supports mental healthcare practitioners. Moodpath connects doctors and patients with a collaborative digital infrastructure, improving efficiency, accessibility and outcome for all stakeholders in the mental healthcare system.

Most Popular Now

What the Radiologist should Know about A…

This paper aims to provide a review of the basis for application of AI in radiology, to discuss the immediate ethical and professional impact in radiology, and to consider possible...

The Mobile Game that can Detect Alzheime…

A specially designed mobile phone game can detect people at risk of Alzheimer's - according to new research from the University of East Anglia. Researchers studied gaming data from an...

Hospital Diagnoses Critically Ill Childr…

The Rady Children’s Hospital (San Diego, USA) used Moon, software developed by the Leuven-based (Belgium) company Diploid. Moon is the first software worldwide to use Artificial Intelligence (AI) for the...

AstraZeneca Starts Artificial Intelligen…

AstraZeneca and BenevolentAI began a long-term collaboration to use artificial intelligence (AI) and machine learning for the discovery and development of new treatments for chronic kidney disease (CKD) and idiopathic...

Novartis Presents First-of-its-Kind Algo…

Novartis today announced results from a validation study of the innovative, algorithm-based digital solution MS Progression Discussion Tool, or MSProDiscussTM. The tool aims to support and facilitate a discussion between...

Bayer Joins Sensyne Health Consortium Wo…

Sensyne Health plc (LSE: SENS), the British clinical AI technology company, and Bayer, the life sciences company, announce that Bayer has become Sensyne Health's preferred pharmaceutical partner to work together...

Red Hat Helps Public Health England Use …

Red Hat, Inc. (NYSE: RHT), the world's leading provider of open source solutions, announced that Public Health England (PHE), an executive agency of the Department of Health and Social Care...

Chipmunk Health Chooses Philips HealthSu…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced that telehealth service provider Chipmunk Health, with locations in the Netherlands and Canada, is leveraging the capabilities...

Siemens Healthineers and European Societ…

With their first course under the heading "Intelligence. Innovation. Imaging - The perfect vision of AI," held in Barcelona on April 5-6, Siemens Healthineers and the European Society of Radiology...

Mobile Prenatal App Shown to Reduce in-P…

Using the mobile app Babyscripts reduced in-person prenatal care visits while maintaining patient and provider satisfaction, according to research published in JMIR mHealth and uHealth by physician researchers from the...